To further elucidate the role of CypA in drug resistance, we performed CypA knockdown in resistant NSCLC cell lines (A459/DDP, A549/DTX, H1299/DDP, H1299/DTX). This evidence concerns the gene PPIA and non-small cell lung carcinoma.